Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NSA2 ribosome biogenesis factor is a highly conserved nucleolar protein involved in the assembly and biogenesis of the large (60S) ribosomal subunit[1][3]. It is essential for cell cycle regulation and cell proliferation. NSA2 is not considered a classic therapeutic target such as a receptor, enzyme, or transporter; rather, it is one of several ribosome biogenesis factors necessary for proper ribosome assembly. Increased expression of NSA2 has been observed in certain disease states, such as diabetic nephropathy. Multiple alternative splice variants and pseudogenes have been identified for NSA2[1][3]. The protein may play a role in the quality control of pre-60S ribosomal particles, but no direct drug targeting or clinical biomarker usage is currently described[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NSA2 ribosome biogenesis factor (NSA2).